Pharma-Bio Serv, Inc. (PBSV)

Pharma-Bio Serv Balance Sheet

Financials in millions USD. Fiscal year is November - October.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	10.45	14.46	17.47	17.14	15.49
Short-Term Investments	4.53	0	0	0	0
Cash & Cash Equivalents	14.98	14.46	17.47	17.14	15.49
Cash Growth	3.56%	-17.21%	1.93%	10.64%	-3.63%
Receivables	3.94	4.98	4.61	10.98	10.03
Inventory	0	0	0	0	0
Other Current Assets	0.48	0.5	0.74	0.47	0.45
Total Current Assets	19.4	19.94	22.82	28.58	25.97
Property, Plant & Equipment	0.39	0.58	0.75	1.06	0.29
Long-Term Investments	4,527	0	0	0	0
Other Long-Term Assets	-4,526.52	0.13	0.35	0.27	0.37
Total Long-Term Assets	0.5	0.71	1.1	1.33	0.66
Total Assets	19.9	20.65	23.92	29.92	26.63
Accounts Payable	1.47	1.63	2.07	1.94	1.59
Deferred Revenue	-2,000.67	0	0	0	0
Current Debt	0.15	0.14	0.13	1.46	0.01
Other Current Liabilities	2,001	0.34	0.45	0.39	2.07
Total Current Liabilities	2.15	2.11	2.65	3.79	3.67
Long-Term Debt	0.19	0.35	0.49	1.33	0.07
Other Long-Term Liabilities	1.43	1.64	1.87	2.08	2.29
Total Long-Term Liabilities	1.62	1.99	2.36	3.41	2.36
Total Liabilities	3.78	4.09	5.01	7.2	6.03
Total Debt	0.35	0.49	0.62	2.79	0.08
Debt Growth	-28.90%	-21.06%	-77.88%	3474.08%	30.63%
Common Stock	0	0	0	0	0
Retained Earnings	14.85	15.27	17.71	21.52	19.47
Comprehensive Income	0.21	0.24	0.14	0.16	0.14
Shareholders' Equity	16.13	16.56	18.91	22.72	20.61
Total Liabilities and Equity	19.9	20.65	23.92	29.92	26.63
Net Cash / Debt	14.63	13.98	16.85	14.35	15.41
Net Cash / Debt Growth	4.69%	-17.06%	17.46%	-6.92%	-3.76%
Net Cash Per Share	0.64	0.61	0.73	0.62	0.67
Working Capital	17.25	17.84	20.17	24.79	22.3
Book Value Per Share	0.70	0.72	0.82	0.99	0.89

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.